Hermann Lübbert
Chief Executive Officer bei BIOFRONTERA INC.
Vermögen: 17 644 $ am 30.04.2024
Aktive Positionen von Hermann Lübbert
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOFRONTERA INC. | Chief Executive Officer | 26.05.2023 | - |
Chairman | 01.03.2015 | - | |
President | 01.03.2015 | - | |
Ruhr-Universität Bochum | Corporate Officer/Principal | - | - |
Biofrontera Bioscience GmbH
Biofrontera Bioscience GmbH Financial ConglomeratesFinance Part of Biofrontera AG, Biofrontera Bioscience GmbH is a German commercial biotech company that provides high-quality treatment options in photodynamic therapy and topical antibiotics. The private company is based in Leverkusen, Germany. The CEOs of the company are Thomas Schaffer, Hermann Lübbert. | Chief Executive Officer | - | - |
Karriereverlauf von Hermann Lübbert
Ehemalige bekannte Positionen von Hermann Lübbert
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOFRONTERA AG | Chief Executive Officer | 01.01.1997 | 13.12.2021 |
Director of Finance/CFO | - | - | |
Founder | 01.01.1997 | 13.12.2021 | |
Biofrontera Pharma GmbH
Biofrontera Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The company is based in Leverkusen, Germany. The CEOs are María del Pilar de la Huerta Martínez, Montserrat Foguet. The private company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005. | Chief Executive Officer | - | - |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - | - |
Ausbildung von Hermann Lübbert
Universität zu Köln | Doctorate Degree |
Statistik
International
Deutschland | 6 |
Schweiz | 2 |
Vereinigte Staaten | 2 |
Operativ
Chief Executive Officer | 4 |
Corporate Officer/Principal | 2 |
Director of Finance/CFO | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BIOFRONTERA AG | Health Technology |
BIOFRONTERA INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Biofrontera Pharma GmbH
Biofrontera Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The company is based in Leverkusen, Germany. The CEOs are María del Pilar de la Huerta Martínez, Montserrat Foguet. The private company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005. | Commercial Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Biofrontera Bioscience GmbH
Biofrontera Bioscience GmbH Financial ConglomeratesFinance Part of Biofrontera AG, Biofrontera Bioscience GmbH is a German commercial biotech company that provides high-quality treatment options in photodynamic therapy and topical antibiotics. The private company is based in Leverkusen, Germany. The CEOs of the company are Thomas Schaffer, Hermann Lübbert. | Finance |
- Börse
- Insiders
- Hermann Lübbert
- Erfahrung